Rapid testing technology for COVID-19

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: IAA-OXF-1

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    UK Research and Innovation (UKRI)
  • Principle Investigator

    Pending
  • Research Location

    China, Western Pacific
  • Lead Research Institution

    COVID-19 Community based surveillance for communities affected by extractive
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    Gender

  • Study Subject

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Impact Acceleration Account Funding: Rapid testing technology for COVID-19:Scientists from University of Oxford and the Oxford Suzhou Centre for Advanced Research (OSCAR) have developed a rapid testing technology for the novel corona virus SARS-CoV-2 (COVID-19). The team, led by Professor Zhanfeng Cui and Professor Wei Huang, have been working to improve test capabilities as the virus spreads internationally.The new test is much faster and does not need a complicated instrument. Previous viral RNA tests took 1.5 to 2 hours to give a result. The research team has developed a new test, based on a technique which is capable of giving results in just half an hour - over three times faster than the current method.Additionally, the technology is very sensitive. This means that patients in early stages of infection may be identified sooner, potentially helping to reduce the spread of the coronavirus SARS-CoV-2 (COVID-19). The technology only requires a simple heat-block which maintains a constant temperature for RNA reverse transcription and DNA amplification, and the results can be read by the naked eye. This makes it potentially useful in rural area or community healthcare centres.The technology has been validated with real clinical samples at Shenzhen Luohou People's Hospital in China. Shenzhen Luohou People's Hospital has applied the rapid detection kits on 16 clinic samples, including 8 positives and 8 negatives, which have been confirmed by conventional RT-PCR methods and other clinical evidence. The test results using the rapid detection kits were all successful.The Oxford scientists are now working to develop an integrated device so that the test can be used at clinics, airports, or even for home use. The project was initiated by Oxford Suzhou Centre for Advanced Research (OSCAR), a University of Oxford centre in Suzhou Industrial Park, China. The experiments to develop the technology were performed in the Department of Engineering Science.